The New York Times / New England Journal / Vita Inc. / /
Country
Mexico / United States / /
Currency
USD / /
Event
FDA Phase / /
Facility
National Cancer Institute / Mayo Clinic / /
IndustryTerm
cancer therapy / cancer therapies / cancer treatment / treatment of cancer / manufacturing / interstate transportation / /
MedicalCondition
gastric carcinoma / intestinal fermentation cancer / controlled existing cancers / terminal cancer / illness / hopelessly advanced cancer / physical suffering / cancers / terminally ill cancer / conventional cancer / cancer / disease / pain / traditional cancer / injuries / disorders / /
MedicalTreatment
cancer therapy / cancer therapies / /
Organization
House Energy and Commerce Committee / National Cancer Institute / U.S. District Court for the Western District of Oklahoma / U.S. District Court / Senate / Congress / Health and Environment Subcommittee of the House Energy / U.S. House of Representatives / U.S. Food and Drug Administration / FDA / American Cancer Society / Laetrile / /
Person
John F. Kennedy / Glenn Rutherford / Ernst Krebs / Ernst Krebs / Jr. / Franz Inglefinger / Luther Bohanon / Bill Goodling / Donald Kennedy / William Curran / Charles Moertel / /
Position
editor / President / physician / head / senior scientist / Judge / Lawyer / distinguished former editor / /
Product
Laetrile tablets / Laetrile / B-17 / /
ProvinceOrState
Oklahoma / California / /
PublishedMedium
The New York Times / the New England Journal of Medicine / /
Manufacture and Regulation of Laetrile By Tom Beauchamp It has been estimated that consumers waste $500 million a year on medical quackery and another $500 million annually on some "health foods" which have no beneficial